BEIJING, Nov. 10, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the Company plans to release third quarter financial results on Wednesday, November 17, 2010, after market close.
The Company will hold a conference call at 8:00 am ET on Thursday, November 18, 2010 to discuss third quarter 2010 results. Listeners may access the call by dialing:
| United States toll free: | 1-866-788-0544 |
| China toll free: | 400-8811629 |
| Hong Kong toll free: | 800-963844 |
| United Kingdom toll free: | 0808-2347616 |
| International: | 1-857-350-1682 |
| Passcode: | 41795291 |
A telephone replay will be available beginning two hours after the conclusion of the call and will be available through November 25, 2010. Listeners may access the replay by dialing:
| United States toll free: | 1-888-286-8010 |
| International: | 1-617-801-6888 |
| Passcode: | 24825087 |
A webcast will also be available through the Company's website www.nkbp.com. ;
About China Nuokang Bio-Pharmaceutical Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Aiduo®, a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com for more information.